Implications of antibiotic use during the COVID-19 pandemic
DOI:
https://doi.org/10.33448/rsd-v10i7.15684Keywords:
Cross infection; Antibiotics; SARS-COV-2; COVID-19; Health.Abstract
We know that nosocomial infection is also a huge problem, especially during the pandemic, where there is a huge demand and few health professionals, thus jeopardizing even the hygiene that occurs quickly to attend patients promptly. In these environments there are also protocols that are already used to prevent or treat bacteria, with the Covid protocol also using antibiotics, this can lead to a future chaos of bacterial resistance. This work intends to evaluate articles that talk about the use of antibiotics in patients with COVID-19, in order to present what may lead to a future increase in the resistance of bacteria, making treatment difficult. Data were collected using the scientific bases: Latin American and Caribbean Literature in Health Sciences (LILACS), National Library of medicine (PUBMED), PERIODICOS, SCIENCE DIRECT, Virtual Health Library - (BVS), Scientific Eletronic Library Online (SCIELO), Cochrane Library, HighWire Press, Scopus and Elsevier. The published works were analyzed and compared for greater relevance of the results and evaluating the data on the use of antibiotics for patients with SARS-CoV-2. A total of 21 articles were found in the scientific bases: Latin American and Caribbean Literature in Health Sciences (LILACS), National Library of medicine (PUBMED), PERIODICOS, SCIENCE DIRECT, Virtual Health Library - (BVS), Scientific Eletronic Library Online (SCIELO), Cochrane Library, HighWire Press, Scopus and Elsevier. The following descriptors were used: HOSPITAL INFECTION, ANTIBIOTICS, SARS-COV-2, COVID-19 in English, Portuguese and Spanish. Where we obtained the articles described below in table 1 and discussed in the form of topics related to the theme. \ In this work we can see that there is a need for hygiene not only to avoid contagion in patients, but also to reduce bacterial or fungal growth, also the use of personal protective equipment. Where since the beginning of the pandemic, there have been a large number of cases, and thus increasing co-infections due to nosocomial infections. We observed that each service has a peculiarity of hygiene and service organization.
References
Beigelman, A. et al. (2015). Randomized trial to evaluate azithromycin's effects on serum and upper airway IL-8 levels and recurrent wheezing in infants with respiratory syncytial virus bronchiolitis. Journal of Allergy and Clinical Immunology, 135(5), 1171-8. e1.
Centers For Disease Control And Prevention. (2020). Interim Guidance for Emergency Medical Services (EMS) Systems and 911 Public Safety Answering Points (PSAPs) for COVID-19 in the United States.
Chen, N., Zhou, M., Dong, X., Qu, J., Gong, F., Han, Y.& Yu, T. (2020). Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. The Lancet, 395(10223), 507-513.
Clancy, C. J., & Nguyen, M. H. (2020). COVID-19, superinfections and antimicrobial development: What can we expect? Clinical Infectious Diseases.
Gerberding, J. L. (2020). Antibiotic resistance: the hidden threat lurking behind Covid-19.STAT.
Hopkins, J. (2020). New Cases of COVID-19 In World Countries. university and medicine. https://coronavirus.jhu.edu/data/new-cases
Hsu, J. (2020). How covid-19 is accelerating the threat of antimicrobial resistance.BMJ, 369.
Huang, C., Wang, Y., Li, X., Ren, L., Zhao, J., Hu, Y. & Cheng, Z. (2020). Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. The lancet, 395(10223), 497-506.
Jin, Y. H., Cai, L., Cheng, Z. S., Cheng, H., Deng, T., Fan, Y. P. & Han, Y. (2019). For the Zhongnan Hospital of Wuhan University Novel Coronavirus Management and Research Team.Evidence-Based Medicine Chapter of China International Exchange and Promotive Association for Medical and Health Care (CPAM). A rapid advice guideline for the diagnosis and treatment of.
Lansbury, L., Lim, B., Baskaran, V., & Lim, W. S. (2020). Co-infections in people with COVID-19: a systematic review and meta-analysis.Journal of Infection.
Lupia, T., Scabini, S., Pinna, S. M., Di Perri, G., De Rosa, F. G., & Corcione, S. (2020). 2019-novel coronavirus outbreak: A new challenge. Journal of Global Antimicrobial Resistance.
Mehta, P., Mcauley, D. F., Brown, M., Sanchez, E., Tattersall, R. S., Manson, J. J., & Hlh AcrossSpeciality Collaboration. (2020). COVID-19: consider cytokine storm syndromes and immunosuppression.Lancet (London, England), 395(10229), 1033.
Meier, M. A., Branche, A., Neeser, O. L., Wirz, Y., Haubitz, S., Bouadma, L. & Christ-crain, M. (2019). Procalcitonin-guided antibiotic treatment in patients with positive blood cultures: a patient-level meta-analysis of randomized trials. Clinical Infectious Diseases,69(3), 388-396.
Miranda, V. S. G., Rech, R. S., Maahs, M. A. P. (2020). Relatos. Revista Enfermagem Atual In Derme | edição especial covid19 – e-020013.
Mohammadpour, S., Torshiziesfahani, A., Halaji, M., Lak, M., & Ranjbar, R. (2020). Uma revisão atualizada da associação de fatores genéticos do hospedeiro com susceptibilidade e resistência ao COVID ‐ 19. Journal of Cellular Physiology.Research, Society and Development, 9(9), e841997245, http://dx.doi.org/10.33448/rsd-v9i9.
Nota Técnica GVIMS/GGTES/ANVISA Nº 07/2020 Orientações para prevenção e vigilância epidemiológica das infecções por SARS-COV-2 (Covid- 19) dentro dos serviços de saúde.
Pani, A., Lauriola, M., Romandini, A., & Scaglione, F. (2020). Macrolídeos e infecções virais: enfoque na azitromicina na patologia de COVID-19. International Journal of Antimicrobial Agents, 106053
PEREIRA, A.S.et al. (2018). Metodologia da pesquisa científica. UFSM
Phelan, A. L., Katz, R., & Gostin, L. O. (2020). The novel coronavirus originating in Wuhan, China: challenges for global health governance. Jama, 323(8), 709-710.
Rawson, T. M., Moore, L. S., Zhu, N., Ranganathan, N., Skolimowska, K., Gilchrist, M. & Holmes, A. (2020). Bacterial and fungal co-infection in individuals with coronavirus: A rapid review to support COVID-19 antimicrobial prescribing. Clinical Infectious Diseases.
Silva, K. M. R. da., Silva, P. B. da., Silva, H. J. N. da., Silva, P. T. da., Silva, B. L., Ferreira, A. M. C., Bezerra, W. A. dos S., Silva, D. de A. e., Campos, M. R. de., Oliveira, D. M. T. e., Nascimento, A. L. L. do., Ribeiro, A. M. de C., Silva, A. M. da., Sousa, E. A., Oliveira, I. K. F., Lopes, M. M. F., Andrade, N. B. de., Pinheiro, I. M., Ferreira, K. L. C., Furtado, D. R. L. (2021). Evaluation of the main pharmacies used for the sars-cov-2: a scientific and technological prospection. Research, Society and Development. 10(3), e19310313136, 10.33448/rsd-v10i3.13136.
Stevens, M. P., Patel, P. K., & Nori, P. (2020). Involving antimicrobial stewardship programs in COVID-19 response efforts: all hands on deck. Infection Control & Hospital Epidemiology, 41(6), 744-745.
Thompson III, G. R., Cornely, O. A., Pappas, P. G., Patterson, T. F. Hoenigl, M., Jenks, J. D. & Nguyen, M. H. (2020). Invasive Aspergillosis as an Underrecognized Superinfection in COVID-19. InOpen Forum Infectious Diseases. 7(7), p. ofaa242). US: Oxford University Press.
Zhang, J., Ma, X., Yu, F., Liu, J., Zou, F., Pan, T., & Zhang, H. (2020). Teicoplanin potently blocks the cell entry of 2019-nCoV. BioRxiv.
Zhou, F., Yu, T., Du, R., Fan, G., Liu, Y., Liu, Z. & Guan, L. (2020). Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. The Lancet.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2021 Kelly Maria Rego da Silva; Rosania Maria de Araújo Oliveira; Antônio José Rufino de Oliveira Araújo; Christiny Carvalho Couto de Paula; Paula da Silva Tavares; Fabiana de Souza Santana; Anna Letícia de Sousa Marinho; Damila Tajra Melo; Dilbert Silva Velôso; José Felipe Pinheiro do Nascimento Vieira; Amanda Miranda da Silva; Higo José Neri da Silva; Anna Erika Pinheiro da Silva; Manuelle Rodrigues da Silva; Márcia Laís Fortes Rodrigues Mattos
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
1) Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
2) Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
3) Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
